DK0984934T3 - Hidtil ukendte oralt aktive jern(III)chelateringsmidler - Google Patents
Hidtil ukendte oralt aktive jern(III)chelateringsmidlerInfo
- Publication number
- DK0984934T3 DK0984934T3 DK98922968T DK98922968T DK0984934T3 DK 0984934 T3 DK0984934 T3 DK 0984934T3 DK 98922968 T DK98922968 T DK 98922968T DK 98922968 T DK98922968 T DK 98922968T DK 0984934 T3 DK0984934 T3 DK 0984934T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrogen
- aryl
- group
- aralkyl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9711093.6A GB9711093D0 (en) | 1997-05-29 | 1997-05-29 | Novel orally active iron (III) chelators |
PCT/GB1998/001517 WO1998054138A1 (en) | 1997-05-29 | 1998-05-26 | Novel orally active iron (iii) chelators |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0984934T3 true DK0984934T3 (da) | 2003-05-05 |
Family
ID=10813233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98922968T DK0984934T3 (da) | 1997-05-29 | 1998-05-26 | Hidtil ukendte oralt aktive jern(III)chelateringsmidler |
Country Status (12)
Country | Link |
---|---|
US (2) | US6335353B1 (de) |
EP (1) | EP0984934B1 (de) |
JP (1) | JP2002500663A (de) |
AT (1) | ATE230728T1 (de) |
AU (1) | AU751600B2 (de) |
CA (1) | CA2287907C (de) |
DE (1) | DE69810619T2 (de) |
DK (1) | DK0984934T3 (de) |
ES (1) | ES2187025T3 (de) |
GB (1) | GB9711093D0 (de) |
WO (1) | WO1998054138A1 (de) |
ZA (1) | ZA984635B (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1220870B1 (de) | 1999-10-01 | 2012-04-11 | DMI Biosciences, Inc. | Metall bindende verbindungen und ihre verwendungen |
US6426418B1 (en) | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
WO2003065991A2 (en) | 2002-02-05 | 2003-08-14 | Bristol-Myers Squibb Company | N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
US8058442B2 (en) | 2002-11-07 | 2011-11-15 | Technion Research And Development Foundation Ltd. | Neuroprotective iron chelators and pharmaceutical compositions comprising them |
NZ529657A (en) * | 2003-11-20 | 2004-07-30 | Apotex Inc | Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
CA2488034C (en) * | 2004-11-19 | 2009-10-06 | Apotex Inc. | Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
GB0506677D0 (en) * | 2005-04-01 | 2005-05-11 | Btg Int Ltd | Iron modulators |
TWI404533B (zh) * | 2007-03-28 | 2013-08-11 | Apotex Technologies Inc | 去鐵酮(deferiprone)之氟化衍生物 |
GB0803019D0 (en) * | 2008-02-19 | 2008-03-26 | Btg Int Ltd | Fluorinated compounds |
UA102254C2 (ru) | 2008-04-25 | 2013-06-25 | Апотекс Технолоджис Инк. | Жидкий состав для деферипрона с приятным вкусом |
KR101695807B1 (ko) | 2008-07-25 | 2017-01-13 | 비이브 헬쓰케어 컴퍼니 | 화합물 |
ES2964383T3 (es) | 2008-12-11 | 2024-04-05 | Viiv Healthcare Co | Procesos e intermedios para inhibidores de la integrasa del VIH de carbamoilpiridona |
MX2011006241A (es) | 2008-12-11 | 2011-06-28 | Shionogi & Co | Sintesis de inhibidores de integrasa de vih de carbamoil-piridona e intermediarios. |
TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
CN102712591B (zh) | 2009-07-03 | 2014-06-25 | 阿普泰克斯科技公司 | 3-羟基吡啶-4-酮的氟化衍生物 |
TWI582097B (zh) | 2010-03-23 | 2017-05-11 | Viiv醫療保健公司 | 製備胺甲醯吡啶酮衍生物及中間體之方法 |
CN109438405B (zh) * | 2018-12-24 | 2023-04-07 | 广东莱佛士制药技术有限公司 | 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法 |
WO2020132820A1 (zh) * | 2018-12-24 | 2020-07-02 | 广东莱佛士制药技术有限公司 | 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法 |
CN111606879A (zh) * | 2020-05-25 | 2020-09-01 | 安徽金禾实业股份有限公司 | 一锅法制备2-羟甲基-3-烷氧基-4h-吡喃-4-酮的方法 |
CN113121423B (zh) * | 2021-03-10 | 2022-07-22 | 浙江工业大学 | Ala杂合3-羟基吡啶酮衍生物及其制备方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1518098A1 (de) * | 1963-09-19 | 1969-04-10 | Pfizer & Co C | Verfahren zur Herstellung von Pyromekonsaeurederivaten |
US3468915A (en) * | 1966-04-18 | 1969-09-23 | Pfizer & Co C | Novel 2-substituted-6-methylpyromeconic acids |
JPS5921954B2 (ja) * | 1980-02-13 | 1984-05-23 | 新日本製鐵株式会社 | 鋼材の防錆処理方法 |
US5112968A (en) * | 1989-07-28 | 1992-05-12 | E. R. Squibb & Sons, Inc. | Monobactam hydrazide derivatives |
GB9006522D0 (en) * | 1990-03-23 | 1990-05-23 | Hider Robert C | Metal complexes |
DE59611243D1 (de) * | 1995-09-29 | 2005-08-11 | Novartis Ag | Hydroxypyridinone |
-
1997
- 1997-05-29 GB GBGB9711093.6A patent/GB9711093D0/en not_active Ceased
-
1998
- 1998-05-26 AT AT98922968T patent/ATE230728T1/de not_active IP Right Cessation
- 1998-05-26 AU AU75427/98A patent/AU751600B2/en not_active Ceased
- 1998-05-26 DE DE69810619T patent/DE69810619T2/de not_active Expired - Fee Related
- 1998-05-26 JP JP50036299A patent/JP2002500663A/ja not_active Ceased
- 1998-05-26 CA CA002287907A patent/CA2287907C/en not_active Expired - Fee Related
- 1998-05-26 WO PCT/GB1998/001517 patent/WO1998054138A1/en active IP Right Grant
- 1998-05-26 ES ES98922968T patent/ES2187025T3/es not_active Expired - Lifetime
- 1998-05-26 DK DK98922968T patent/DK0984934T3/da active
- 1998-05-26 EP EP98922968A patent/EP0984934B1/de not_active Expired - Lifetime
- 1998-05-29 ZA ZA9804635A patent/ZA984635B/xx unknown
-
1999
- 1999-11-10 US US09/437,211 patent/US6335353B1/en not_active Expired - Lifetime
-
2001
- 2001-09-04 US US09/944,113 patent/US6506911B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6506911B2 (en) | 2003-01-14 |
US20020068758A1 (en) | 2002-06-06 |
CA2287907A1 (en) | 1998-12-03 |
DE69810619D1 (de) | 2003-02-13 |
DE69810619T2 (de) | 2003-09-25 |
US6335353B1 (en) | 2002-01-01 |
EP0984934A1 (de) | 2000-03-15 |
CA2287907C (en) | 2009-01-13 |
ATE230728T1 (de) | 2003-01-15 |
EP0984934B1 (de) | 2003-01-08 |
AU751600B2 (en) | 2002-08-22 |
ZA984635B (en) | 1999-11-29 |
AU7542798A (en) | 1998-12-30 |
JP2002500663A (ja) | 2002-01-08 |
GB9711093D0 (en) | 1997-07-23 |
ES2187025T3 (es) | 2003-05-16 |
WO1998054138A1 (en) | 1998-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0984934T3 (da) | Hidtil ukendte oralt aktive jern(III)chelateringsmidler | |
NZ332363A (en) | substituted 4-hydroxy-isoquinoline-3carboxamide derivatives and medicaments | |
UA39869C2 (uk) | Похідні аспартаму або їх фізіологічно прийнятні солі, спосіб їх отримання та підсолоджувальна композиція | |
DE3275295D1 (en) | Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them | |
ES477457A1 (es) | Procedimiento de preparacion de amidas de alcohilendiaminas. | |
ES8103734A1 (es) | Procedimiento para preparar nuevos derivados de piperidina | |
ES8405364A1 (es) | Metodo de preparar amidoaminoacidos n-substituidos. | |
CA2304713A1 (en) | Biphenyl-5-alkanoic acid derivatives and use thereof | |
ES8207156A1 (es) | Procedimiento para la preparacion de nuevas pirimidinonas . | |
ES2172093T3 (es) | Nuevas composiciones cosmeticas que comprenden un polimero filmogeno. | |
GR3031517T3 (en) | RARy-specific retinobenzoic acid derivatives | |
ES8605506A1 (es) | Procedimiento para preparar derivados de piperidina | |
FI810389L (fi) | Foerfarande foer framstaellning av substituerade imidazolderivat | |
ATE28187T1 (de) | Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung. | |
ES8607218A1 (es) | Un procedimiento para preparar compuestos de amidina | |
ZA816259B (en) | 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants | |
ES457001A1 (es) | Un procedimiento de preparacion de derivados de fenetilamina. | |
ES8404976A1 (es) | Procedimiento para preparar nuevos derivados de encefalina. | |
IE792300L (en) | 2,4, 6-triiodoisophthalamic acid derivatives; x-ray¹contrast agents | |
ES8301895A1 (es) | "procedimiento para preparar nuevos acidos 2-amino-3-(halobenzoil)-metilfenilaceticos,sus esteres y sus sales metalicas". | |
IL67023A (en) | Substituted thiazolidinyl esters of phosphoric and sulfuric acid | |
ATE206431T1 (de) | Antifungal fusacandine | |
ES8608873A1 (es) | Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-piridiln-furilmetil propilaminas. | |
ES476713A1 (es) | Procedimiento para la preparacion de derivados del acido carboxilico de 1,5-ciclohexadieno sustituido. | |
ES8302734A1 (es) | Procedimiento para preparar 5'-n-(aminoalquil)-amino-5'-deo-xiadenosina |